Jiaoyang Liao

机构：ShanghaiTech University, East China Normal University · ORCID：0000-0002-0443-563X

发表论文 25 篇 · 总被引 879 次 · h-index 14

代表论文

• Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells (2014 · Cell Research · 被引 245)
• CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia (2022 · Nature Medicine · 被引 179)
• Therapeutic adenine base editing of human hematopoietic stem cells (2023 · Nature Communications · 被引 80)
• Imbalance of Excitatory/Inhibitory Neuron Differentiation in Neurodevelopmental Disorders with an NR2F1 Point Mutation (2020 · Cell Reports · 被引 71)
• CRISPR-Cas9-mediated genome editing in one blastomere of two-cell embryos reveals a novel Tet3 function in regulating neocortical development (2017 · Cell Research · 被引 48)
• Distinct enhancer signatures in the mouse gastrula delineate progressive cell fate continuum during embryo development (2019 · Cell Research · 被引 45)